Effects of bariatric surgery and dietary intervention on insulin resistance and appetite hormones over a 3 year period.
- Publisher:
- NATURE PORTFOLIO
- Publication Type:
- Journal Article
- Citation:
- Sci Rep, 2023, 13, (1), pp. 6032
- Issue Date:
- 2023-04-13
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
Effects of bariatric surgery and dietary intervention on insulin resistance and appetite hormones over a 3 year period.pdf | Published version | 1.16 MB | Adobe PDF |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Brzozowska, MM | |
dc.contributor.author | Isaacs, M | |
dc.contributor.author | Bliuc, D | |
dc.contributor.author | Baldock, PA | |
dc.contributor.author | Eisman, JA | |
dc.contributor.author | White, CP | |
dc.contributor.author | Greenfield, JR | |
dc.contributor.author | Center, JR | |
dc.date.accessioned | 2024-06-24T22:38:09Z | |
dc.date.available | 2023-04-11 | |
dc.date.available | 2024-06-24T22:38:09Z | |
dc.date.issued | 2023-04-13 | |
dc.identifier.citation | Sci Rep, 2023, 13, (1), pp. 6032 | |
dc.identifier.issn | 2045-2322 | |
dc.identifier.issn | 2045-2322 | |
dc.identifier.uri | http://hdl.handle.net/10453/179637 | |
dc.description.abstract | To examine an impact of three types of bariatric surgery compared with dietary intervention (DIET), on concurrent changes in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) and appetite hormones over 3 years. Fifty-five adults were studied during phase of weight loss (0-12 months) and during weight stability (12-36 months) post intervention. Measurements of HOMA-IR, fasting and postprandial PYY and GLP1, adiponectin, CRP, RBP4, FGF21 hormones and dual-Xray absorptiometry were performed throughout the study. All surgical groups achieved significant reductions in HOMA-IR with greatest difference between Roux-en-Y gastric bypass and DIET (- 3.7; 95% CI - 5.4, - 2.1; p = 0.001) at 12-36 months. Initial (0-12 months) HOMA-IR values were no different to DIET after adjustment for the lost weight. During 12-36 months, after controlling for treatment procedure and weight, for every twofold increase in postprandial PYY and adiponectin, HOMA-IR decreased by 0.91 (95% CI - 1.71, - 0.11; p = 0.030) and by 0.59 (95% CI - 1.10, - 0.10; p = 0.023) respectively. Initial, non-sustained changes in RBP4 and FGF21 were not associated with HOMA-IR values. While initial rapid weight loss reduces insulin resistance, the enhanced secretions of PYY and adiponectin may contribute to weight-independent improvements in HOMA-IR during weight stability.Clinical trial registration: Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12613000188730. | |
dc.format | Electronic | |
dc.language | eng | |
dc.publisher | NATURE PORTFOLIO | |
dc.relation.ispartof | Sci Rep | |
dc.relation.isbasedon | 10.1038/s41598-023-33317-6 | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Insulin Resistance | |
dc.subject.mesh | Appetite | |
dc.subject.mesh | Adiponectin | |
dc.subject.mesh | Australia | |
dc.subject.mesh | Bariatric Surgery | |
dc.subject.mesh | Gastric Bypass | |
dc.subject.mesh | Insulin | |
dc.subject.mesh | Weight Loss | |
dc.subject.mesh | Blood Glucose | |
dc.subject.mesh | Retinol-Binding Proteins, Plasma | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Insulin Resistance | |
dc.subject.mesh | Weight Loss | |
dc.subject.mesh | Insulin | |
dc.subject.mesh | Blood Glucose | |
dc.subject.mesh | Gastric Bypass | |
dc.subject.mesh | Appetite | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Australia | |
dc.subject.mesh | Bariatric Surgery | |
dc.subject.mesh | Adiponectin | |
dc.subject.mesh | Retinol-Binding Proteins, Plasma | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Insulin Resistance | |
dc.subject.mesh | Appetite | |
dc.subject.mesh | Adiponectin | |
dc.subject.mesh | Australia | |
dc.subject.mesh | Bariatric Surgery | |
dc.subject.mesh | Gastric Bypass | |
dc.subject.mesh | Insulin | |
dc.subject.mesh | Weight Loss | |
dc.subject.mesh | Blood Glucose | |
dc.subject.mesh | Retinol-Binding Proteins, Plasma | |
dc.title | Effects of bariatric surgery and dietary intervention on insulin resistance and appetite hormones over a 3 year period. | |
dc.type | Journal Article | |
utslib.citation.volume | 13 | |
utslib.location.activity | England | |
pubs.organisational-group | University of Technology Sydney | |
pubs.organisational-group | University of Technology Sydney/Faculty of Engineering and Information Technology | |
pubs.organisational-group | University of Technology Sydney/Faculty of Engineering and Information Technology/School of Biomedical Engineering | |
utslib.copyright.status | closed_access | * |
dc.date.updated | 2024-06-24T22:38:06Z | |
pubs.issue | 1 | |
pubs.publication-status | Published online | |
pubs.volume | 13 | |
utslib.citation.issue | 1 |
Abstract:
To examine an impact of three types of bariatric surgery compared with dietary intervention (DIET), on concurrent changes in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) and appetite hormones over 3 years. Fifty-five adults were studied during phase of weight loss (0-12 months) and during weight stability (12-36 months) post intervention. Measurements of HOMA-IR, fasting and postprandial PYY and GLP1, adiponectin, CRP, RBP4, FGF21 hormones and dual-Xray absorptiometry were performed throughout the study. All surgical groups achieved significant reductions in HOMA-IR with greatest difference between Roux-en-Y gastric bypass and DIET (- 3.7; 95% CI - 5.4, - 2.1; p = 0.001) at 12-36 months. Initial (0-12 months) HOMA-IR values were no different to DIET after adjustment for the lost weight. During 12-36 months, after controlling for treatment procedure and weight, for every twofold increase in postprandial PYY and adiponectin, HOMA-IR decreased by 0.91 (95% CI - 1.71, - 0.11; p = 0.030) and by 0.59 (95% CI - 1.10, - 0.10; p = 0.023) respectively. Initial, non-sustained changes in RBP4 and FGF21 were not associated with HOMA-IR values. While initial rapid weight loss reduces insulin resistance, the enhanced secretions of PYY and adiponectin may contribute to weight-independent improvements in HOMA-IR during weight stability.Clinical trial registration: Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12613000188730.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph